O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors

NCT00275002 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

NIH

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: O6-benzylguanine
DRUG: temozolomide

Sponsor

National Cancer Institute (NCI)